Validation of Hemorrhoidal Bleeding Score

Completed

• Conditions: Hemorrhoid Bleeding

• Registration Number: NCT03060616
• Lead Sponsor: Fondation Hôpital Saint-Joseph

Brief Summary

The principal manifestation of hemorrhoidal disease is bleeding; however the severity evaluation is today based on prolapsus (Goligher classification) and bleeding factor is not included.

Even if there was some rare score including bleeding in literature , none of them were validated.

The aim of the study is first validation of bleeding score .

Detailed Description

Not available

Study Timeline

• Study Start: 2016-09-01
• Study First Submitted: 2017-02-16
• Study First Submitted QC: 2017-02-18
• Study First Posted: 2017-02-23
• Primary Completion: 2018-03-15
• Study Completion: 2018-03-15
• Status Verified: 2023-04
• Last Update Submitted: 2023-04-26
• Last Update Posted: 2023-04-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 130

Inclusion Criteria

• Age>18 years
• consulting for hemorroidal bleeding
• accept to participate

Exclusion Criteria

• paraplegic or hemiplegic patient
• Misunderstanding of the French language

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
assessment of bleeding score	1 day

Trial Locations

Locations (1)

Groupe Hospitalier Paris Saint Joseph; 🇫🇷 Paris, Ile-de-France, France